Dosimetry of iodoantipyrine.

Dosimetry of iodoantipyrine labeled with radioactive iodine was determined by measuring the biodistribution of 131I-iodoantipyrine in 41 female rabbits. Following administration of the radiopharmaceutical, subjects were killed at 0.5, 6, 12, 17, 24, 36, and 48 h. Organs and samples of tissues and body fluids were assayed. Results were corrected for physical decay. Exponential functions were employed to describe the time-concentration curves; representative value would be the biological half life of 9.96 +/- 0.55 h for blood. Cumulated activity estimates for 123I, 125I and 131I were then computed. Extrapolation to absorbed dose in humans followed the formulation of the Medical International Radiation Dose (MIRD) Committee of the Society of Nuclear Medicine. The whole body absorbed doses are 7 mu Gray, 5 mu Gray and 29 mu Gray per MBq of 123I, 125I, and 131I administered respectively.